GM Advisory Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Sell |
4,845
-1
| -0% | -$70 | 0.02% | 226 |
|
|
2025
Q1 | $356K | Buy |
4,846
+1
| +0% | +$74 | 0.02% | 202 |
|
|
2024
Q4 | $317K | Sell |
4,845
-123
| -2% | -$8.06K | 0.02% | 203 |
|
|
2024
Q3 | $387K | Buy |
4,968
+123
| +3% | +$9.58K | 0.02% | 181 |
|
|
2024
Q2 | $378K | Sell |
4,845
-75
| -2% | -$5.85K | 0.02% | 171 |
|
|
2024
Q1 | $333K | Sell |
4,920
-95
| -2% | -$6.44K | 0.02% | 177 |
|
|
2023
Q4 | $338K | Buy |
5,015
+170
| +4% | +$11.4K | 0.03% | 167 |
|
|
2023
Q3 | $328K | Buy |
+4,845
| New | +$328K | 0.03% | 150 |
|